MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers personal lines of property and casualty insurance, including private passenger automobile, homeowners', and personal excess liability insurance. Further, it provides fixed and variable annuities, and pension products; accident and health products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
IPO Year: 2000
Exchange: NYSE
Website: metlife.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/5/2024 | $91.00 | Overweight | Barclays |
1/8/2024 | $80.00 | Neutral → Buy | Goldman |
11/17/2023 | $71.00 | Overweight | Barclays |
10/5/2023 | $71.00 | Hold | Deutsche Bank |
9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
12/9/2022 | $86.00 → $82.00 | Buy → Hold | Jefferies |
9/22/2022 | Mkt Perform | Raymond James | |
6/23/2022 | $70.00 → $74.00 | Peer Perform → Outperform | Wolfe Research |
5/24/2022 | $77.00 | Buy | Citigroup |
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.41713578 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest
MetLife, Inc. (NYSE:MET) today announced its second quarter 2024 results. Second Quarter Results Summary Net income of $912 million, or $1.28 per share, compared to net income of $370 million, or $0.48 per share, in the second quarter of 2023. Adjusted earnings of $1.6 billion, or $2.28 per share, compared to adjusted earnings of $1.5 billion, or $1.94 per share, in the second quarter of 2023. Book value of $33.30 per share, down 5 percent from $34.92 per share at June 30, 2023. Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $53.12 per share, down 1 percent from $53.55 per share at June 30, 202
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a second quarter 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731828416/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help i
MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a third quarter 2024 common stock dividend of $0.545 per share. The dividend will be payable on Sept. 10, 2024, to shareholders of record as of Aug. 6, 2024. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and
MetLife, Inc. (NYSE:MET) today announced that it will hold its second quarter 2024 earnings conference call on Thursday, August 1, 2024, from 9-10 a.m. (ET). The call will follow MetLife's issuance of its second quarter 2024 earnings news release and Second Quarter 2024 Financial Supplement on Wednesday, July 31, 2024, after the market closes. The news release and Second Quarter 2024 Financial Supplement will also be available on the MetLife Investor Relations webpage (https://investor.metlife.com). The conference call will be available live via the internet. To listen to the conference call, click the following link to register (https://registrations.events/direct/Q4I79508686). The con
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.43023800 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cu
MetLife, Inc. (NYSE:MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $600 million remaining at the end of April 2024 under the company's prior authorization announced in May 2023. "This $3 billion addition to our share repurchase authorization, combined with the common stock dividend increase we announced in April, demonstrates our commitment to returning capital to shareholders, which is carefully balanced with investing in responsible growth for the future," said MetLife President and CEO Michel Khalaf. "Our disciplined approach directs ca
MetLife, Inc. (NYSE:MET) today announced its first quarter 2024 results. First Quarter Results Summary Net income of $800 million, or $1.10 per share, compared to net income of $14 million, or $0.02 per share, in the first quarter of 2023. Adjusted earnings of $1.3 billion, or $1.83 per share, compared to adjusted earnings of $1.2 billion, or $1.52 per share, in the first quarter of 2023. Book value of $34.54 per share, down 6 percent from $36.89 per share at March 31, 2023. Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $53.13 per share, down 1 percent from $53.83 per share at March 31, 2023.
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a first quarter 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240501662440/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help indi
MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a second quarter 2024 common stock dividend of $0.545 per share, an increase of 4.8% from the first quarter common stock dividend of $0.52 per share. MetLife has increased its common stock quarterly dividend at an 8.7% compound annual growth rate since 2011. The dividend will be payable on June 11, 2024, to shareholders of record as of May 7, 2024. "We are pleased to increase our common dividend per share by 4.8%, which attests to our balanced approach to capital deployment focused on growing our business and returning capital to our shareholders to drive long-term value," said MetLife President and CEO Mi
Sponsorship highlights MetLife's enduring commitment in support of HBCU students MetLife, Inc. (NYSE:MET) today announced it is partnering with the Toyota HBCUNY Classic presented by Walmart for the third consecutive year. Featuring a matchup of renowned HBCU schools Howard University and Morehouse College, the football game will take place at MetLife Stadium on September 14, 2024, at 3:00 p.m. ET. The event marks the start of HBCU homecoming week and will showcase spectacular drumline performances and a battle of the bands between the participating schools during halftime. MetLife's sponsorship builds on MetLife and MetLife Foundation's long and rich history of enabling access to educati
MetLife, Inc. (NYSE:MET) today announced that it has named Toby Srihiran Brown global head of reinsurance, effective Oct. 1. To address the expanding scope of MetLife's reinsurance activities, Brown will develop and maintain a comprehensive reinsurance strategy for the company, overseeing the end-to-end reinsurance process, including deal origination, structuring, negotiation, execution, and ongoing monitoring and reporting. He will report to John McCallion, chief financial officer, MetLife, Inc., and head of MetLife Investment Management. Brown, currently MetLife's chief auditor, will be succeeded in that role by Rob Dill, MetLife's chief financial officer for the Latin America region.
MetLife, Inc. (NYSE:MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management will participate in a fireside chat at the 2024 Keefe, Bruyette & Woods Insurance Conference on Thursday, Sept. 5 beginning at approximately 9:05 a.m. (ET). A live audio webcast of the presentation will be available over the internet at (https://wsw.com/webcast/kbw109/met/1596980). Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation will be av
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has named Jude Driscoll its president, effective Sept. 1. Previously serving as MIM's global head of Fixed Income and Private Capital, Driscoll will continue to report to John McCallion, MetLife's chief financial officer and head of MetLife Investment Management. The two will collaborate in driving MIM's strategy and business operations. "Jude is the ideal leader to assume the role of president and support MIM in continuing to enhance its client service and offerings, and realize its growth ambitions," said McCallion. "Jude's deep understanding of our cli
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.41713578 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest
LOS ANGELES, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet care industry, today announced MetLife Pet Insurance, has been selected as the 2024 "Pet Insurance Of The Year". MetLife Pet Insurance offers protection for all stages of a pet's life with robust annual benefit amount options, chronic care coverage and no lifetime or per-incident limits. MetLife Pet Insurance plans are also highly customizable, allowing pet parents to select the deductibles, annual benefit limits and reimbursement percentages that best suit their personal situations.
MetLife, Inc. (NYSE:MET) today announced its second quarter 2024 results. Second Quarter Results Summary Net income of $912 million, or $1.28 per share, compared to net income of $370 million, or $0.48 per share, in the second quarter of 2023. Adjusted earnings of $1.6 billion, or $2.28 per share, compared to adjusted earnings of $1.5 billion, or $1.94 per share, in the second quarter of 2023. Book value of $33.30 per share, down 5 percent from $34.92 per share at June 30, 2023. Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $53.12 per share, down 1 percent from $53.55 per share at June 30, 202
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a second quarter 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731828416/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help i
New Chief Data and Analytics Officer and Chief Information Security Officer Join One of the World's Leading Financial Services Companies MetLife, Inc. (NYSE:MET) today added two accomplished and experienced leaders to their Global Technology and Operations organization. Tamar Shapiro will join MetLife as their Chief Data and Analytics Officer and Dan Antilley becomes the company's Chief Information Security Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240730440379/en/Tamar Shapiro will join MetLife as their Chief Data and Analytics Officer (Photo: Business Wire) Shapiro was the Head of Analytics at Instagram where s
$20,000 grant to be awarded to an organization that helps large dogs find loving homes MetLife Pet Insurance today announced the creation of the Golden Beagle Award. This award will recognize an animal welfare organization for its innovative approach to addressing the challenges of helping larger dogs find loving homes. The recipient will receive $20,000 to put toward their work. The award is part of MetLife Pet Insurance's collaboration with The Association for Animal Welfare Advancement (AAWA), a cohort of leaders on a mission to champion, advance, and unify the animal welfare profession. "Essential to MetLife Pet Insurance's mission is helping pets find and stay in a home that is rig
Citigroup analyst Michael Ward maintains MetLife (NYSE:MET) with a Buy and raises the price target from $83 to $89.
Throughout the last three months, 9 analysts have evaluated MetLife (NYSE:MET), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 6 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 3 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 3 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $84.0, a high estimate of $86.00, and a low estimate of $80.00. Observing a 0.13% increase, the current average has risen from
Jefferies analyst Suneet Kamath maintains MetLife (NYSE:MET) with a Buy and raises the price target from $83 to $86.
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $82 to $83.
Keefe, Bruyette & Woods analyst Ryan Krueger maintains MetLife (NYSE:MET) with a Outperform and lowers the price target from $86 to $85.
MetLife's (NYSE:MET) short percent of float has risen 4.76% since its last report. The company recently reported that it has 9.16 million shares sold short, which is 1.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.4 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is impor
JP Morgan analyst Jimmy Bhullar maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $81 to $86.
Ratings for MetLife (NYSE:MET) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 7 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 3 0 0 0 3M Ago 0 4 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $84.0, a high estimate of $87.00, and a low estimate of $80.00. Witnessing a positive shift, the current av
Jefferies analyst Suneet Kamath maintains MetLife (NYSE:MET) with a Buy and lowers the price target from $88 to $83.
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
N-PX - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
13F-HR - METLIFE INC (0001099219) (Filer)
10-Q - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
144 - METLIFE INC (0001099219) (Subject)
144/A - METLIFE INC (0001099219) (Subject)
8-K - METLIFE INC (0001099219) (Filer)
144 - METLIFE INC (0001099219) (Subject)
144 - METLIFE INC (0001099219) (Subject)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00
Goldman upgraded MetLife from Neutral to Buy and set a new price target of $80.00
Barclays resumed coverage of MetLife with a rating of Overweight and set a new price target of $71.00
Deutsche Bank initiated coverage of MetLife with a rating of Hold and set a new price target of $71.00
Jefferies upgraded MetLife from Hold to Buy and set a new price target of $72.00 from $58.00 previously
Goldman downgraded MetLife from Buy to Neutral and set a new price target of $78.00 from $80.00 previously
Jefferies downgraded MetLife from Buy to Hold and set a new price target of $82.00 from $86.00 previously
Raymond James initiated coverage of MetLife with a rating of Mkt Perform
Wolfe Research upgraded MetLife from Peer Perform to Outperform and set a new price target of $74.00 from $70.00 previously
Citigroup initiated coverage of MetLife with a rating of Buy and set a new price target of $77.00
Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such
MetLife's John Wilson takes over for Kramden founder, who headed the board for two decades As a part of MetLife's, Inc. (NYSE:MET) global strategy to increase diversity in Science, Technology, Engineering and Math (STEM), the company today announced that John Wilson was named chair of the Board of Kramden Institute, a North Carolina non-profit that provides technology and training to bridge the digital divide. Wilson takes over the chair position from the organization's founder, Mark Dibner, who has overseen Kramden's growth for the last 20 years. "We are blessed to have a board of directors passionate about technology and social impact," said Cyndy Yu-Robinson, Kramden Executive Direct
Sofía Belmar to take new role with Latin America regional team and be succeeded by Mario Valdes, who currently oversees six operations in Central and Eastern Europe These changes reinforce MetLife's commitment to cross-region talent development and succession planning After six years of successfully leading MetLife's operation in Mexico – the company's third-largest global operation – Sofía Belmar-Berumen will be taking a new regional role as Head of Business Development and Transformation, Latin America. Belmar's leadership and business acumen have been critical for MetLife Mexico to become the leading player in the local insurance industry. A prominent thought leader, she is the first
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (“MetLife”), announced today that James Reid has been named CEO of Versant Health, a managed vision care company and wholly owned subsidiary of MetLife. The appointment is effective April 1. “James brings extensive and varied experience in the Group Benefits market to Versant Health,” said Todd Katz, chairman of the Versant Health Board of Directors and executive vice president, Group Benefits at MetLife. “His dedication to delivering for customers, focus on building talent and background in both sales and general management makes him ideally suited to lead Versant to new levels of growth.” Reid brings more than 30 years of experience in
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a first quarter 2021 common stock dividend of $0.46 per share. The dividend will be payable on March 15, 2021, to shareholders of record as of Feb. 5, 2021. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United